Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
source : Www.biospace.com    save search
Kala Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call
Published: 2022-03-23 (Crawled : 13:30) - biospace.com/
KALA | $6.5661 4.24% 1.1K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 1.21% C: -4.4%
conference report results
Rani Therapeutics Announces Initiation of Phase 1 Study of RT-102 Oral PTH for Osteoporosis
Published: 2022-03-23 (Crawled : 13:30) - biospace.com/
RANI | $6.87 2.69% 2.62% 140K twitter stocktwits trandingview |
| | O: -1.29% H: 6.06% C: 3.07%
rt-102 therapeutics osteoporosis phase 1 phase 3
Allogene Therapeutics Announces Preclinical Publication Highlighting Superiority of Healthy Donor-Derived Allogeneic CAR T Cells Over Patient-Derived Cells in Multiple Myeloma
Published: 2022-03-23 (Crawled : 13:30) - biospace.com/
ALLO | $3.04 -9.79% -10.86% 2.1M twitter stocktwits trandingview |
Health Technology
 | | O: -1.1% H: 2.84% C: -1.62%
therapeutics preclinical t-cell pre-clinical
Graphite Bio Announces Formation of Scientific Advisory Board
Published: 2022-03-23 (Crawled : 13:30) - biospace.com/
GRPH 4 | $3.27 1.84% 490K twitter stocktwits trandingview |
Professional, Scientific, and T...
 | | O: -1.3% H: 1.32% C: -7.4%
Arcadia Biosciences (RKDA) Announces Date of Fourth-Quarter and Full-Year 2021 Financial Results and Business Highlights Conference Call
Published: 2022-03-23 (Crawled : 13:00) - biospace.com/
RKDA | $2.035 0.24% 0.24% 20K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 21.43% C: 16.67%
conference results
BiomX to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast on March 30, 2022
Published: 2022-03-23 (Crawled : 13:00) - biospace.com/
PHGE | $0.3274 -5.51% 3.82% 130K twitter stocktwits trandingview |
Health Technology
 | | O: -1.76% H: 5.3% C: 3.03%
conference results
TC BioPharm Receives MHRA and Research Ethics Committee Approvals to Initiate Phase 2B/3 Clinical Trials for the Treatment of Acute Myeloid Leukemia
Published: 2022-03-23 (Crawled : 13:00) - biospace.com/
TCBP | $1.485 -6.01% -6.4% 110K twitter stocktwits trandingview |
| | O: -4.16% H: 21.74% C: 15.65%
treatment trials leukemia research myeloid leukemia acute myeloid leukemia phase 2b
Thermo Fisher Scientific to Support National Program to Accelerate SARS-CoV-2 Variant Identification
Published: 2022-03-23 (Crawled : 13:00) - biospace.com/
TMO | News | $577.39 0.49% 0.0% 2M twitter stocktwits trandingview |
Health Technology
 | | O: -1.66% H: 0.0% C: 0.0%
program sars-cov-2
Mednow Achieves Record Q2 2022 Financial Results with 230% Q/Q Revenue Growth and 1,400% Y/Y Revenue Growth
Published: 2022-03-23 (Crawled : 12:30) - biospace.com/
DNOW | $14.77 -2.51% 0.0% 740K twitter stocktwits trandingview |
Distribution Services
 | | O: 0.87% H: 2.68% C: 1.44%
results growth
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2021 Financial Results
Published: 2022-03-23 (Crawled : 12:30) - biospace.com/
RXRX | $7.94 3.12% 3.02% 7.1M twitter stocktwits trandingview |
Professional, Scientific, and T...
 | | O: -1.0% H: 5.64% C: -0.14%
results
XORTX Files New PCT Patent to Treat and Protect Individuals Most at Risk to Severe Viral InfectionCompositions and Methods for Enhancing Anti-Viral Therapies
Published: 2022-03-23 (Crawled : 12:30) - biospace.com/
XRTX | News | $2.88 -2.41% 11K twitter stocktwits trandingview |
Mining, Quarrying, and Oil and ...
 | | O: 8.26% H: 89.31% C: 32.82%
risk patent
Rezolute Announces Positive Results from the Phase 2b RIZE Study of RZ358 in Congenital Hyperinsulinism
Published: 2022-03-23 (Crawled : 12:30) - biospace.com/
RZLT 4 | $2.91 1.75% 1.72% 340K twitter stocktwits trandingview |
Technology Services
 | | O: 19.84% H: 5.22% C: -10.43%
rz358 positive results phase 2b
Moderna Announces its COVID-19 Vaccine Phase 2/3 Study in Children 6 Months to Under 6 Years Has Successfully Met Its Primary Endpoint
Published: 2022-03-23 (Crawled : 12:30) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M twitter stocktwits trandingview |
Health Technology
 | | O: -1.1% H: 0.59% C: -3.21%
covid-19 children vaccine phase 2
Aytu BioPharma Announces FDA Orange Book Listing of Newly Issued Patent for Cotempla XR-ODT(R)
Published: 2022-03-23 (Crawled : 12:30) - biospace.com/
AYTU | $2.74 0.92% 0.91% 14K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 1.75% C: -2.63%
fda biopharma patent
Merck Announces Retirement of Dr. Roy D. Baynes; Dr. Eliav Barr Appointed Head of Global Clinical Development and Chief Medical Officer
Published: 2022-03-23 (Crawled : 12:30) - biospace.com/
MRK | $127.0 0.1% -1.21% 7.1M twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 1.61% C: 0.54%
Zynex Recognized as Fourth Largest Biotechnology/Bioscience Company in Colorado
Published: 2022-03-23 (Crawled : 12:30) - biospace.com/
ZYXI | $11.245 -0.13% -0.13% 130K twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 9.03% C: 4.52%
bioscience
Eikon Therapeutics Announces the Appointment of Dr. Roy D. Baynes as Executive Vice President and Chief Medical Officer
Published: 2022-03-23 (Crawled : 12:30) - biospace.com/
TVTX | $5.46 -4.88% -5.13% 2M twitter stocktwits trandingview |
Health Technology
 | | O: -0.99% H: 2.31% C: -1.59%
NTRA | News M | $91.47 0.47% 0.47% 810K twitter stocktwits trandingview |
Health Services
 | | O: 3.44% H: 0.0% C: 0.0%
ATRA | $0.7101 -1.18% -1.2% 700K twitter stocktwits trandingview |
Health Technology
 | | O: -2.44% H: 1.88% C: -2.92%
therapeutics
Pluristem Releases PLX-R18 Hematology Phase I Study Results: Data Show Increase in All Blood Lines and Reduction in Blood Transfusions
Published: 2022-03-23 (Crawled : 12:00) - biospace.com/
PSTI | $1.0 -2.91% 8.0% twitter stocktwits trandingview |
Health Technology
 | | O: -1.97% H: 8.04% C: 4.02%
blood
VectivBio Presents Preclinical Data Supporting Apraglutide for Treatment of Acute Graft-Versus-Host Disease at the 48th Annual Meeting of the European Society for Blood and Marrow Transplantation
Published: 2022-03-23 (Crawled : 12:00) - biospace.com/
VECT | $16.85 0.12% 130K twitter stocktwits trandingview |
Professional, Scientific, and T...
 | | O: -8.22% H: 6.11% C: 1.83%
treatment blood disease preclinical pre-clinical
UPDATE -- CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; Natera Intentionally Deceived Transplant Community
Published: 2022-03-23 (Crawled : 12:00) - biospace.com/
NTRA | News M | $91.47 0.47% 0.47% 810K twitter stocktwits trandingview |
Health Services
 | | O: 3.44% H: 0.0% C: 0.0%
CDNA | $7.995 -2.86% -2.94% 520K twitter stocktwits trandingview |
Health Technology
 | | O: -2.81% H: 4.35% C: -2.69%
trial
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services
BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services
WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services
AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services
MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information
RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance
Your saved searches
Save your searches and get alerts when important news are released.